Article
Researchers from Mount Sinai School of Medicine in New York say they have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer.
Intervention to increase fluid intake does not reduce recurrent stones
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
FDA to host advisory committee meeting on UGN-102 for NMIBC
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
AUA Advocacy Summit: Medicare payment reform among top priorities
AUA 2025 recap: Urologic oncology trials in progress